 Includes oral presentation for 1.5 mgkg cold urticaria cohort Company to host webcast conference call on Tuesday, December 6 at 8:00 am ET HAMPTON, N.J., Dec. 02, 2022 GLOBE NEWSWIRE Celldex Therapeutics, Inc. NASDAQ:CLDX announced today that multiple presentations from the barzolvolimab development program will be presented at the 6th ... The post Celldex Therapeutics Announces Multiple Upcoming Presentations of Barzolvolimab Data at GA2LEN Global Urticaria Forum GUF 2022 appea... 